Related Experiment Video
Updated: May 24, 2026

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Does pathway analysis make it easier for common variants to tag rare ones?
Hae-Won Uh1, Roula Tsonaka, Jeanine J Houwing-Duistermaat
1Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. h.uh@lumc.nl.
Analyzing rare genetic variants in sequencing data is challenging. Pathway analysis can improve detection by weighting rare variants more heavily, enhancing the identification of disease susceptibility genes.
Area of Science:
- Genetics
- Bioinformatics
- Statistical genomics
Background:
- Analyzing low-frequency rare variants in sequencing data presents challenges due to reduced statistical power for association detection.
- Existing pathway analysis methods, often designed for common variants in genome-wide association studies, may be suboptimal for sequencing data.
- Identifying susceptibility genes requires robust methods that can jointly analyze both common and rare variants.
Purpose of the Study:
- To evaluate the performance of existing pathway analysis methods with sequencing data.
- To investigate whether pathway-level analysis offers an improved strategy for identifying susceptibility genes.
- To adapt and enhance methods for joint analysis of common and rare variants.
Main Methods:
- Investigated the performance of several established pathway analysis techniques on sequencing data.
- Focused on the global test approach, which does not account for linkage disequilibrium within genes.
- Adapted the global test by incorporating a weighted-sum approach, assigning greater importance to rare variants.
Main Results:
- Direct application of standard pathway analysis methods to sequencing data proved unsatisfactory.
- The weighted-sum approach, by increasing the weight of rare variants, demonstrated improved performance.
- Joint analysis of common and rare variants requires specific weighting strategies.
Conclusions:
- Standard pathway analysis methods require adaptation for effective use with sequencing data.
- Assigning higher weights to rare variants is crucial for improving the power of pathway analysis.
- The weighted-sum approach offers a promising strategy for identifying susceptibility genes through joint variant analysis.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Principles of Pharmacogenetics: Types of Genetic Variants
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs